WINDTREE THERAPEUTICS INC /DE/ Quarterly Other Liabilities, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Windtree Therapeutics Inc /De/ quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Other Liabilities, Noncurrent for the quarter ending June 30, 2024 was $3.8M, unchanged year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.8M $0 0% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $3.8M $0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $3.8M $0 0% Dec 31, 2023 10-Q 2024-08-19
Q3 2023 $3.8M $0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.8M $0 0% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $3.8M $0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.8M $0 0% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $3.8M +$200K +5.56% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.8M +$600K +18.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.8M +$1M +35.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.8M +$1M +35.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $3.6M +$1.2M +50% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.2M +$2.2M +220% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $2.8M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.8M Dec 31, 2020 10-K 2022-03-31
Q3 2020 $2.4M +$2.29M +2164% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $1M +$906K +964% Jun 30, 2020 10-Q 2020-08-14
Q3 2019 $106K -$60K -36.1% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $94K -$88K -48.4% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $63K -$30K -32.3% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 $175K +$75K +75% Dec 31, 2018 10-K 2020-04-03
Q3 2018 $166K +$49K +41.9% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $182K +$58K +46.8% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $93K -$38K -29% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 $100K -$38K -27.5% Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 $117K -$38K -24.5% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $124K -$38K -23.5% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 $131K +$91K +228% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $138K +$95K +221% Dec 31, 2016 10-K 2018-04-17
Q3 2016 $155K +$99K +177% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $162K +$103K +175% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 $40K -$156K -79.6% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $43K -$126K -74.6% Dec 31, 2015 10-K 2017-03-31
Q3 2015 $56K -$86K -60.6% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $59K -$55K -48.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $196K -$518K -72.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $169K -$369K -68.6% Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 $142K -$289K -67.1% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $114K -$319K -73.7% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $714K +$233K +48.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $538K +$95K +21.4% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $431K -$239K -35.7% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $433K -$253K -36.9% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $481K -$222K -31.6% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $443K -$246K -35.7% Dec 31, 2012 10-K 2014-03-17
Q3 2012 $670K -$21K -3.04% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $686K -$22K -3.11% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $703K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $689K +$55K +8.68% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $691K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $708K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $634K Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.